I don't see material upside or downside (for Boston Scientific shares) for the next 12 months.

If the deals went to shareholders today, we believe Boston Scientific would prevail.

In Boston they ask, how much does he know? In New York, how much is he worth? In Philadelphia, who were his parents?

If they do negotiate a lower price, they may open themselves up to litigation by essentially conceding that there has been a problem under management's watch.

You can't just sit back on your laurels. You have to constantly innovate.

I think a lot of folks had not expected them to be back this quickly.